SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-005176
Filing Date
2013-04-30
Accepted
2013-04-30 16:00:43
Documents
6
Period of Report
2013-06-03
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214400zdef14a.htm DEF 14A 465400
2 G225377.JPG g225377.jpg GRAPHIC 14090
3 G38833.JPG g38833.jpg GRAPHIC 6983
4 G950541.JPG g950541.jpg GRAPHIC 10633
5 G17792BGI001.GIF g17792bgi001.gif GRAPHIC 109708
6 G17792BGI002.GIF g17792bgi002.gif GRAPHIC 46771
  Complete submission text file 0001047469-13-005176.txt   726538
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals, Inc. (Filer) CIK: 0001411158 (see all company filings)

IRS No.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34973 | Film No.: 13797369
SIC: 2834 Pharmaceutical Preparations